Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing emphasis on outsourcing of testing services
3.2.1.2 Technological advancements in testing equipment
3.2.1.3 Extensive growth in research and development investments
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent government regulations and compliance
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
3.8 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Services, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Genetic services
5.3 Biomarker services
5.4 Microbiology services
5.5 Anatomic pathology/histology
5.6 Specimen management & storage
5.7 Other services
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Oncology
6.3 Neurology
6.4 Cardiology
6.5 Infectious diseases
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Pharmaceutical and biotechnology companies
7.3 Academic and research institutes
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 A.P. Moller Holding A/S
9.2 ACM Global Laboratories
9.3 BioAgilytix Labs
9.4 Cerba Research
9.5 Cirion Biopharma Research Inc.
9.6 Covance Inc.
9.7 Eurofins Scientific
9.8 Frontage Laboratories
9.9 ICON Central Laboratories
9.10 LabConnect
9.11 Laboratory Corporation of America Holding
9.12 Lambda Therapeutics Research Ltd
9.13 Medpace, Inc.
9.14 Parexel International Corporation
9.15 Quest Diagnostics
9.16 Versiti
